Trial Profile
A trial of erlotinib in patients with metastatic pulmonary adenocarcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Erlotinib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 10 Dec 2015 New trial record